re: Ann: New Data Supports PAT-SM6 Profile as... How bonkers is this market. I can honestly say I've never sold a PAB share. I even bought in 2010 at 21cents, yet the biggest volume and news in the companies history and it can't crack 3.5 cents.
A company that the market sees as a trading proposition only and is disregarding the science.
It will no doubt when this pump and dump is finished will return to the 2 cent area.
The market will only recognise this company like all other biotech ASX companies when there's money invested into it by a pharmaceutical co.
Ann: New Data Supports PAT-SM6 Profile as Anti-ca, page-9
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $6.172M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $7.419K | 2.372M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 56 | 40557809 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 26688875 | 13 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| PAB (ASX) Chart |